|參考文獻||尤明村. 2003.生物高分子-PHA的生物相容性之評估. 輔仁大學生命科學所碩士論文.
蔡良. 2004.嗜鹽菌產生之聚羥基烷酯類生物相容性評估及PHA在生醫材料應用上的評估. 輔仁大學生命科學所碩士論文.
Ali SA, Doherty PJ, Williams DF. Molecular biointeractions of biomedical polymers with extracellular exudate and inflammatory cell and their effects on biocompatibility in vivo. Biomaterials 1994; 15: 779-85.
Baier, R. E., De Palma. V. A., Groupil, D. W., Cohen, E.J. Human platelet spreading on substrata of known surface chemistry. Biomed. Mater. Res. 1985; 19: 1157-67
Baud L, Ardaillou R. Tumor necrosis factor in renal injury. Miner Electrolyte Metab 1995; 21: 336-341.
Baumann H, Gauldie J. The acute phase response. Immunol Today 1994; 15: 74-80.
Cheng S, Chen GQ, Leski M, Zou B, Wang Y, Wu Q. The effect of D,L-β-hydroxy -butyric acid on cell death and proliferation in L929 cells. Biomaterials 2006; 27: 3758–3765
Cheng S, Wu Q, Yang F, Xu M, Leski M, Chen GQ. Influence of DL-β-Hydroxy -butyric Acid on Cell Proliferation and Calcium Influx. Biomacromolecules. 2005; 6: 593-597
Deng Y, Lin XS, Zheng Z, Deng JG, Chen JC, Ma H, Chen GQ. Poly (hydroxybutyrate-co-hydroxyhexanoate) promoted production of extracellular matrix of articular cartilage chondrocytes in vitro. Biomaterials 2003; 23: 4273-81.
Deng Y, Zhao K, Zhang XF, Hu P, Chen GQ. Study on the three-dimensional proliferation of rabbit articular cartilage-derived chondrocytes on polyhydroxyalkanoate scaffolds. Biomaterials 2002; 23: 4049-56.
Fernandez-Castillo RF, Rodriguez-Valera F, Gonzalez-Ramos J, Ruiz-Berrauqero F. Accumulation of poly（β-hydroxybutyrate）by halobacteria. Appl Environ Microbiol 1986; 51: 214-216.
Freier T, Kunze C, Nischan C, Kramer S, Sternberg K, Sass M, Hopt UT, Schmitz KP. In vitro and in vivo degradation studies for development of a biodegradable patch based on poly(3-hydroxybutyrate). Biomaterials 2002; 23: 2649-57.
Gerlach KL, Pesch HJ. In vivo evaluation of a copolymer of polyhydroxybutyrate and polyhydroxyvalerate. Abstracts of the 8th European Conference on Biomaterial, 7-9 th Sept., Heidelberg, 1989; B3-1, P79.
Gerlier D, Thomasset N. Use of MTT colorimetric assay to measure cell activation. J Immunol Methods 1986; 94: 57-63.
Gilding DK. Biodegradable polymers. In: D.F. Williams (Ed.) Biocompatibility of Clinical Implant Materials. CRC Press 1981; 2: 209- 230.
Goldby RA, Kindt TJ, Osborne BA. The leukocyte migration and inflammation.4th. Kuby Immunology. 2000; Chapter 15：338-360
Gogolewski S, Jovanovic M, Perren SM, Dillon JG, Hughes MK. Tissue response and in vivo degradation of selected polyhydroxyacids : polylactides(PLA), poly(3-hydroxybutyrate) (PHB), and poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHB/VA). J Biomed Mater Res 1993; 27: 1135-48.
Grothe JGC, Rodriques MFA, Alli RCP, Torres BB, Bueno CL, Oliveira MS, da Silva LF. Evaluation of soil gram-negative bacteria yielding polyhydroxyalkanoic acids from carbohydrates and propionic acid. Appl microbial Biotechnol 1996; 45: 750-791.
Holland SJ, Jolly AM, Yasin M, Tighe BJ. Polymers for biodegradable medical devices. II. Hydroxybutyrate-hydroxyvalerate copolymers : hydrolytic degradation studies. Biomaterials 1987; 8: 289-95.
Hong J, Azens A, Ekdahl KN, Granqvist CG, Nilsson B, Material-speci.c thrombin generation following contact between metal surfaces and whole blood. Biomaterials 26 (2005) 1397–1403.
ISO 10993. A practical guide to ISO 10993 : Part 1-introduction to the standards, 1992.
ISO 472. Plastics-Vocabulary. 1988.
Keuren J. F., Wielders S. J., Driessen A., Verhoeven M., Hendriks M., Lindhout T. Covalently-bound heparin makes collagen thromboresistant. Arterioscler Thromb Vasc Biol. 2004; 3:613-7.
Kaladhar K, Sharma CP, Supported Cell Mimetic Monolayers and Their Interaction with Blood, Langmuir 2004; 20: 11115-11122.
Kang IK, Kwon OH, Kim MK, Lee YM, Sung YK, In vitro blood compatibility of functional group-grafted and heparin-immobilized polyurethanes prepared by plasma grow discharge. Biomaterials. 1997; 18: 1099-1107.
Kassab AC, Xu K, Denkbas EB, Dou Y, Zhao S, Piskin E. Rifampicin carrying polyhydroxybutyrate microspheres as a potential chemoembolization agent. J Biomater Sci Polym Ed 1997; 12: 947-61.
Kim D., El-Shall H., Dennis D., Morey T. Interaction of PLGA nanoparticles with human blood constituents. Colloids and Surfaces B: Biointerfaces 2005; 40: 83-91.
Korsatko W, Wabnegg B, Tillian HM, Egger G, Pfragner R, Walser V. Studies on biocompatibility of poly-D-(-)-3-hydroxybutyric acid implantation tablets in tissue culture and animals. Pharm Ind 1984; 46: 952-954.
Kronethal RL. Biodegradable polymers in medicine and surgery. Plenum Press, New York. 1974; p126-136.
Lafferty RM, Korsatko B, Korsatko W. Microbial production of poly-3-hydroxybutyric acid. In: Rehm HJ and Reed G(Eds), Biotechnology: A Comprehensive Treatise, Special Microbial Processes, VCH Verlagsgesellschaft, Weinhheim, 1988, vol 6b, p135-176.
Lauxier CA, CJ Monasterios I, Saracovan RH, Marchessault, BA Ramsay. Biodegradable Lattex. Tappi J. 1993; 76: 71-77.
Li J, Yun H, Gong YD, Zhao NM, Zhang XF. Effects of surface modification of poly 3-hydroxybutyrateco-3-hydroxyhexanoate)(PHBHHx) on physicochemical roperties and on interactions with MC3T3-E1 cells. Wiley InterScience. 2005; 64: 985-98.
Majid, MIA. The degradation of PHB and P(HB-HV) copolymers and their uses in drug delivery. Ph D thesis. University of Bath UK. 1988.
Manfred Zinn, Bernard Witholt, Thomas Egli. Occurrence, synthesis and medical application of bacterial polyhydroxyalkanoate. Advanced Drug Delivery Reviews 2001; 53: 5–21.
Meng J, Kong H, Xu HY, Song L, Wang CY, Xie SS, Improving the blood compatibility of polyurethane using carbon nanotubes as fillers and its implications to cardiovascular surgery. Carbon Nanotubes Improve Hemocompatibility 2005.
Mergaert J, Webb A, Anderson C, Wouters A, Swings J. Microbial degradation of poly(3- hydroxbutyrate) and poly(3-hydroxybutyrate-co-3hydroxyvalerate) in soils. Appl. Environ. Microbiiol. 1993; 59: 3233-3238.
Nebe B, Forster C, Pommerenke H, Fulda G, Behrend D, Bernewski U, Schmitz KP, Rychly J. Structural alterations of adhesion mediating components in cells cultured on poly-beta-hydroxy butyric acid. Biomaterials 2001; 17: 2425-34.
Pouton CW. Biocompatibility of polyhydroxybutyrate and related copolymers. Proc Int, Symp. Controlled Release Bioact. Mater 1988; 15: 179-180.
Pouton CW. Degradation of polyhydroxybutyrate and related copolymers. Proc. Int. Symp. Controlled Release Bioact. Mater 1988; 15: 181-183.
Reddy CS, Ghai R, Rashmi, Kalia VC. Polyhydroxyalkanoates : an overview. Bioresour Technol 2003; 87: 137-146.
Reusch RN and Sadoff HL. Putative structure and function of a poly-β-hydroxybutyrate / calcium polyphosphate channel in bacterial plasma memebranes. Proc. Natl. Acad. Sci 1988; 85: 4176-4180.
Reusch RN, Sparrow AW, Gardiner J. Transport of poly-beta-hydroxybutyrate in human plasma. Biochim Biophys Acta 1992; 1123: 33-40.
Rodriguez-Valera F, JG Lillo. Novel biodegradable microbial polymer: Halobacteria as producers of poly-β-hydroxyalkanoates in Novel Biodegradable Microbial polymers. Kluwer Acad. Pub. 1990; p425-426.
Sagnella S, Katanchallee MN, Chitosan based surfactant polymers designed to improve blood compatibility on biomaterials. Colloids and Surfaces B: Biointerfaces; 2005: 42 147–155.
Sevastianov VI, Perova NV, Shishatskaya EI, Kalacheva GS, Volova TG. Production of purified polyhydroxyalkanoates (PHAs) for applications in contact with blood. J Biomater Sci Polym Ed 2003; 10: 1029-42.
Shishatskaya EI, Volova TG. A comparative investigation of biodegradable polyhydroxylalkanoate films as matrices for in vitro cell culture. 2004; 15: 915-923.
Shishatskaya EI, Volova TG, Puzyr AP, Mogilnaya OA, Efremov SN. Tissue reponse to the implantation of biodegradable polyhydroxylalkanoate sutures. Journal of material science: Materials in medicine. 2004; 15: 719-728.
Steinbuchel A, Aerts K, Babel W, Follner C, Liebergesell M, Madkour MH, Mayer F, Pieper-Furst U, Pries A, Valentin HE. Considerations on the structure and biochemistry of bacterial polyhydroxyalkanoic acid inclusions. Can J Microbiol. 41 Suppl 1995; 1: 94-105.
Stewart CC, Riedy MC, Stewart SJ. Introduction: the proliferation and differentiation of macrophages. Immunol Ser 1994; 60: 3-27.
Stuehr DJ, Nathan CF. Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med 1989; 169: 1543-55.
Tatiana Volova, Ekaterina Shishatskaya, Viktor Sevastianov, Sergei Efremov, Olga Mogilnaya, Results of biomedical investigations of PHB and PHB/PHV fibers. Biochemical Engineering Journal 2002; 16: 125-133.
van der Giessen WJ, Lincoff AM, Schwartz RS, van Beusekom HM, Serruys PW, Holmes DR Jr, Ellis SG, Topol EJ. Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries. Circulation 1996; 94: 1690-7.
V. I. Sevastianov, N. V. Perova, E. I. Shishatskaya, G. S. Kalacheva, T. G. Volova, Production of purified polyhydroxyalkanoates（PHAs）for applications in contact with blood. J. Biomater. Sci. Polymer Edn 2003; 14: 1029-1042.
Wang YW, Wu Q, Chen GQ. Reduced mouse fibroblast cell growth by increased hydrophilicity of microbial polyhydroxyalkanoates via hyaluronan coating.Biomaterials 2003; 24: 4621–4629.
William DF. Techniques of Biocompatibility Testing, CRC Press, Boca Raton, FL,1986; vol. 2
Wu CK, Grandahl L, Jack KS, Foo X, Trau M, Hume DA, Cassady AI. Reduction of the in vitro pro-inflammatory response by macrophages to poly(3-hydroxybutyrate-co -3-hydroxyvalerate). Biomaterails. 2006; 27: 4715-4725
Yagmurlu MF, Korkusuz F, Gursel I, Korkusuz P, Ors U, Hasirci V. Sulbactam-cefoperazone polyhydroxybutyrate-co-hydroxyvalerate (PHBV) local antibiotic delivery system : in vivo effectiveness and biocompatibility in the treatment of implant-related experimental osteomyelitis. J Biomed Mater Res 1999; 46: 494-503.
Yang X, Zhao K, Chen GQ. Effect of surface treatment on the biocompatibility of microbial polyhydroxyalkanoates. Biomaterials 2002; 5: 1391-7.
Zhao K, Deng Y, Chen JC, Chen GQ. Polyhydroxyalkanoate (PHA) scaffolds with good mechanical properties and biocompatibility. Biomaterials. 2003; 24:1041–1045.
Zhao K, Yang X, Chen GQ, Chen JC. Effect of lipase treatment on the biocompatibility of microbial polyhydroxylalkanoates. Journal of material science: Materials in medicine. 2002; 13: 849-854.
Zheng Z, Bei FF, Tian HL, Chen GQ. Effects of crystallization of polyhydroxy -alkanoate blend on surface physicochemical properties and interactions with rabbit articular cartilage chondrocytes. Biomaterials. 2005; 16: 3537–3548.
Zheng Z, Deng Y, Lin XS, Zhang LX, Chen GQ. Induced production of rabbit articular cartilage-derived chondrocyte collagen II on polyhydroxyalkanoate blends. J Biomater Sci Polym Ed 2003; 7: 615-24.